tiprankstipranks
Trending News
More News >
Gufic Biosciences Limited (IN:GUFICBIO)
:GUFICBIO
India Market
Advertisement

Gufic Biosciences Limited (GUFICBIO) Ratios

Compare
0 Followers

Gufic Biosciences Limited Ratios

IN:GUFICBIO's free cash flow for Q3 2025 was ₹0.55. For the 2025 fiscal year, IN:GUFICBIO's free cash flow was decreased by ₹ and operating cash flow was ₹0.15. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.61 1.61 1.61 1.72 1.59
Quick Ratio
1.05 1.08 1.08 1.10 1.02
Cash Ratio
0.07 <0.01 <0.01 0.06 0.04
Solvency Ratio
0.16 0.18 0.18 0.45 0.28
Operating Cash Flow Ratio
0.00 -0.02 -0.02 0.56 0.54
Short-Term Operating Cash Flow Coverage
0.00 -0.05 -0.05 7.87 4.47
Net Current Asset Value
₹ 562.36M₹ 404.98M₹ 404.98M₹ 684.70M₹ 419.58M
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.30 0.30 0.12 0.16
Debt-to-Equity Ratio
0.56 0.63 0.63 0.24 0.35
Debt-to-Capital Ratio
0.36 0.38 0.38 0.19 0.26
Long-Term Debt-to-Capital Ratio
0.18 0.22 0.22 0.15 0.17
Financial Leverage Ratio
1.95 2.05 2.05 1.94 2.26
Debt Service Coverage Ratio
0.54 0.66 0.66 7.01 2.34
Interest Coverage Ratio
4.92 18.84 18.84 37.02 5.75
Debt to Market Cap
0.09 0.11 0.11 0.03 0.05
Interest Debt Per Share
35.86 35.34 35.34 7.00 7.56
Net Debt to EBITDA
2.22 2.24 2.24 0.36 0.63
Profitability Margins
Gross Profit Margin
44.93%50.50%50.50%44.86%47.15%
EBIT Margin
14.30%16.14%16.14%16.86%14.25%
EBITDA Margin
16.87%18.35%18.35%19.06%17.97%
Operating Profit Margin
13.86%35.87%35.87%16.57%13.87%
Pretax Profit Margin
11.48%14.34%14.34%16.28%11.83%
Net Profit Margin
8.50%10.68%10.68%12.30%9.07%
Continuous Operations Profit Margin
8.50%10.68%10.68%12.30%9.07%
Net Income Per EBT
73.98%74.47%74.47%75.56%76.64%
EBT Per EBIT
82.85%39.97%39.97%98.25%85.31%
Return on Assets (ROA)
5.96%7.88%7.88%18.38%11.28%
Return on Equity (ROE)
12.21%16.17%16.17%35.61%25.50%
Return on Capital Employed (ROCE)
14.53%40.16%40.16%38.60%29.62%
Return on Invested Capital (ROIC)
8.69%24.27%24.27%27.83%20.60%
Return on Tangible Assets
5.99%7.92%7.92%18.40%11.29%
Earnings Yield
1.87%3.00%3.00%3.97%3.98%
Efficiency Ratios
Receivables Turnover
2.60 2.44 2.44 5.14 3.92
Payables Turnover
2.84 2.40 2.40 3.05 2.32
Inventory Turnover
2.08 1.99 1.99 3.72 2.73
Fixed Asset Turnover
1.57 1.70 1.70 4.11 4.12
Asset Turnover
0.70 0.74 0.74 1.49 1.24
Working Capital Turnover Ratio
6.92 3.99 3.99 6.75 7.18
Cash Conversion Cycle
187.20 180.56 180.56 49.43 69.37
Days of Sales Outstanding
140.22 149.29 149.29 71.00 93.18
Days of Inventory Outstanding
175.33 183.26 183.26 98.18 133.68
Days of Payables Outstanding
128.34 151.99 151.99 119.75 157.48
Operating Cycle
315.55 332.55 332.55 169.18 226.86
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -0.76 -0.76 10.77 9.19
Free Cash Flow Per Share
0.00 -12.19 -12.19 1.61 7.72
CapEx Per Share
0.00 11.43 11.43 9.16 1.47
Free Cash Flow to Operating Cash Flow
0.00 16.11 16.11 0.15 0.84
Dividend Paid and CapEx Coverage Ratio
0.00 -0.07 -0.07 1.16 6.11
Capital Expenditure Coverage Ratio
0.00 -0.07 -0.07 1.18 6.27
Operating Cash Flow Coverage Ratio
0.00 -0.02 -0.02 1.62 1.45
Operating Cash Flow to Sales Ratio
0.00 >-0.01 >-0.01 0.13 0.18
Free Cash Flow Yield
0.00%-4.19%-4.19%0.65%6.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
53.43 33.32 33.32 25.19 25.10
Price-to-Sales (P/S) Ratio
4.54 3.56 3.56 3.10 2.28
Price-to-Book (P/B) Ratio
6.19 5.39 5.39 8.97 6.40
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -23.89 -23.89 154.32 14.83
Price-to-Operating Cash Flow Ratio
0.00 -384.92 -384.92 23.11 12.46
Price-to-Earnings Growth (PEG) Ratio
-3.08 5.27 5.27 0.22 0.26
Price-to-Fair Value
6.19 5.39 5.39 8.97 6.40
Enterprise Value Multiple
29.15 21.63 21.63 16.61 13.30
Enterprise Value
40.31B 32.02B 32.02B 24.67B 11.65B
EV to EBITDA
29.15 21.63 21.63 16.61 13.30
EV to Sales
4.92 3.97 3.97 3.17 2.39
EV to Free Cash Flow
0.00 -26.65 -26.65 157.69 15.57
EV to Operating Cash Flow
0.00 -429.41 -429.41 23.62 13.08
Tangible Book Value Per Share
59.99 53.47 53.47 27.70 17.84
Shareholders’ Equity Per Share
59.99 54.04 54.04 27.76 17.89
Tax and Other Ratios
Effective Tax Rate
0.26 0.26 0.26 0.24 0.23
Revenue Per Share
81.81 81.85 81.85 80.37 50.31
Net Income Per Share
6.95 8.74 8.74 9.89 4.56
Tax Burden
0.74 0.74 0.74 0.76 0.77
Interest Burden
0.80 0.89 0.89 0.97 0.83
Research & Development to Revenue
0.00 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.00 0.14 0.14 0.02 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 -0.09 -0.09 1.09 2.01
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis